Breaking Finance News

A statement released today by Sidoti about Heska Corp (NASDAQ:HSKA) raises the target price to $71.00

Boasting a price of $66.32, Heska Corp (NASDAQ:HSKA) traded -1.09% lower on the day. With the last stock price close up 36.31% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the date range. Heska Corp has recorded a 50-day average of $57.86 and a two hundred day average of $48.13. Volume of trade was down over the average, with 62,844 shares of HSKA changing hands under the typical 107,067

In a statement issued on 11/28/2016 Sidoti upped the price target of Heska Corp (NASDAQ:HSKA) to $71.00 reporting a potential upside of 0.07%.

Performance Chart

Heska Corp (NASDAQ:HSKA)

With a total market value of $0, Heska Corp has price-earnings ratio of 52.52 with a one year low of $26.25 and a one year high of $69.80 .

A total of 4 equity analysts have released a ratings update on HSKA. One equity analyst rating the company a strong buy, three equity analysts rating the company a buy, zero equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $39.88.

Brief Synopsis About Heska Corp (NASDAQ:HSKA)

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *